-
1
-
-
0033821045
-
Short-term prognosis in early relapsing-remitting multiple sclerosis
-
Scott TF, Schramke CJ, Novero J, Chieffe C. Short-term prognosis in early relapsing-remitting multiple sclerosis. Neurology 2000; 55: 689-693.
-
(2000)
Neurology
, vol.55
, pp. 689-693
-
-
Scott, T.F.1
Schramke, C.J.2
Novero, J.3
Chieffe, C.4
-
2
-
-
0029873865
-
Long-term and short-term outcome of multiple sclerosis. A 3-year follow-up study
-
Weinshenker BG, Issa M, Baskerville J. Long-term and short-term outcome of multiple sclerosis. A 3-year follow-up study. Arch Neurol 1996; 53: 353-58.
-
(1996)
Arch Neurol
, vol.53
, pp. 353-358
-
-
Weinshenker, B.G.1
Issa, M.2
Baskerville, J.3
-
3
-
-
0025774940
-
The natural history of multiple sclerosis: A geographically based study: 3. Multivariate analysis of predictive factors and models of outcome
-
Weinshenker BG, Rice GP, Noseworthy JH, Carriere W et al. The natural history of multiple sclerosis: A geographically based study: 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-56.
-
(1991)
Brain
, vol.114
, pp. 1045-1056
-
-
Weinshenker, B.G.1
Rice, G.P.2
Noseworthy, J.H.3
Carriere, W.4
-
4
-
-
0032788240
-
Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors
-
Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67: 148-52.
-
(1999)
J Neurol Neurosurg Psychiatry
, vol.67
, pp. 148-152
-
-
Hawkins, S.A.1
McDonnell, G.V.2
-
5
-
-
0038263335
-
Power
-
In Howell DC ed; Boston, Massachusetts: PWS Publishers
-
Howell DC. Power. In Howell DC ed. Statistical Methods for Psychology. Boston, Massachusetts: PWS Publishers, 1982: 151-70.
-
(1982)
Statistical Methods for Psychology
, pp. 151-170
-
-
Howell, D.C.1
-
6
-
-
4243714651
-
Risk factors for progression in early relapsing-remitting MS
-
Abstract P-411
-
Scott TS, Shramke CJ. Abstract P-411. Risk factors for progression in early relapsing-remitting MS. Mult Scler 2001; 7(Suppl 1): S121.
-
(2001)
Mult Scler
, vol.7
, Issue.SUPPL. 1
-
-
Scott, T.S.1
Shramke, C.J.2
-
7
-
-
0034564732
-
Usefulness of Bayesian graphical models for early prediction of disease progression in multiple sclerosis
-
Bergamaschi R, Romani A, Tonietti S, Citterio A et al. Usefulness of Bayesian graphical models for early prediction of disease progression in multiple sclerosis. Neurol Sci 2000; 21: S819-S823.
-
(2000)
Neurol Sci
, vol.21
-
-
Bergamaschi, R.1
Romani, A.2
Tonietti, S.3
Citterio, A.4
-
8
-
-
0020686503
-
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
-
Poser CM, Paty DW, Scheinberg L, McDonald WI et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
-
(1983)
Ann Neurol
, vol.13
, pp. 227-231
-
-
Poser, C.M.1
Paty, D.W.2
Scheinberg, L.3
McDonald, W.I.4
-
9
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
-
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
10
-
-
0000263693
-
Exacerbation recovery and the progression of multiple sclerosis
-
Lublin FD, Cutter GR, Baier M. Exacerbation recovery and the progression of multiple sclerosis. Neurology 2000; 54(Suppl 3): A216-17.
-
(2000)
Neurology
, vol.54
, Issue.SUPPL. 3
-
-
Lublin, F.D.1
Cutter, G.R.2
Baier, M.3
-
12
-
-
0000784055
-
Interferon beta-1b in secondary progressive MS: Clinical and MRI results of a 3-year randomized controlled trial
-
Abstract
-
Goodkin DE, North American Study Group. Interferon beta-1b in secondary progressive MS: Clinical and MRI results of a 3-year randomized controlled trial. Neurology 2000; 54 2352 Abstract.
-
(2000)
Neurology
, vol.54
, pp. 2352
-
-
Goodkin, D.E.1
-
13
-
-
0035849496
-
Randomized controlled trial of interferon-beta-1a in secondary progressive MS
-
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group. Randomized controlled trial of interferon-beta-1a in secondary progressive MS. Neurology 2001; 56: 1496-1504.
-
(2001)
Neurology
, vol.56
, pp. 1496-1504
-
-
-
14
-
-
4243226828
-
Aspects of multiple sclerosis that relate to clinical trial design and treatment
-
In Rudick, RA, and Goodkin, DE ed; Malden, MA: Blackwell Science Inc.
-
Rudick RA, Goodkin DE. Aspects of multiple sclerosis that relate to clinical trial design and treatment. In Rudick, RA, and Goodkin, DE ed. Multiple Sclerosis Therapeutics Malden, MA: Blackwell Science Inc., 1999.
-
(1999)
Multiple Sclerosis Therapeutics
-
-
Rudick, R.A.1
Goodkin, D.E.2
-
15
-
-
0037161296
-
Randomized controlled trials to assess therapies for multiple sclerosis
-
Wingerchuck DM, Noseworthy JH. Randomized controlled trials to assess therapies for multiple sclerosis. Neurology 2002; 58(Suppl 4): S40-48.
-
(2002)
Neurology
, vol.58
, Issue.SUPPL. 4
-
-
Wingerchuck, D.M.1
Noseworthy, J.H.2
-
16
-
-
0035058217
-
A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
-
Kahn OA, Tselis AC, Kamholz JA, Garbern JY et al. A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. Eur J Neurol 2001; 8: 141-48.
-
(2001)
Eur J Neurol
, vol.8
, pp. 141-148
-
-
Kahn, O.A.1
Tselis, A.C.2
Kamholz, J.A.3
Garbern, J.Y.4
-
17
-
-
0035091667
-
The European/Canadian multicenter, double blind, randomized, placebo controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
-
Comi G, Filippi M, Wolinsky JS and European/Canadian Glatiramer Acetate Study Group. The European/Canadian multicenter, double blind, randomized, placebo controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. Ann Neurol 2001; 49: 290-97.
-
(2001)
Ann Neurol
, vol.49
, pp. 290-297
-
-
Comi, G.1
Filippi, M.2
Wolinsky, J.S.3
-
18
-
-
0023248694
-
A pilot of cop 1 in exacerbating-remitting multiple sclerosis
-
Bornstein MB, Miller A, Slagle S, Weitzman M et al. A pilot of cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 1987; 317: 408-14.
-
(1987)
N Engl J Med
, vol.317
, pp. 408-414
-
-
Bornstein, M.B.1
Miller, A.2
Slagle, S.3
Weitzman, M.4
-
19
-
-
0035170089
-
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis
-
Whitaker JN, Wolinsky JS, Narayana PA, Bartolucci AA et al. Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol 2001; 58: 49-54.
-
(2001)
Arch Neurol
, vol.58
, pp. 49-54
-
-
Whitaker, J.N.1
Wolinsky, J.S.2
Narayana, P.A.3
Bartolucci, A.A.4
-
20
-
-
0035845431
-
Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis
-
Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T et al. Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis. Neurology 2001; 57: 853-57.
-
(2001)
Neurology
, vol.57
, pp. 853-857
-
-
Fazekas, F.1
Strasser-Fuchs, S.2
Kollegger, H.3
Berger, T.4
-
21
-
-
0035196870
-
Oligoclonal band number as a marker for prognosis in multiple sclerosis
-
Avasarala JR, Cross AH, Trotter JL. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 2001; 58: 2044-45.
-
(2001)
Arch Neurol
, vol.58
, pp. 2044-2045
-
-
Avasarala, J.R.1
Cross, A.H.2
Trotter, J.L.3
-
22
-
-
0033586376
-
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis
-
Kappos L, Moeri D, Radue EW, Schweikert K et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Lancet 1999; 353: 964-69.
-
(1999)
Lancet
, vol.353
, pp. 964-969
-
-
Kappos, L.1
Moeri, D.2
Radue, E.W.3
Schweikert, K.4
-
23
-
-
0027225525
-
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine enhancing magnetic resonance imaging lesions
-
Smith ME, Stone LA, Albert PS, Frank JA et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine enhancing magnetic resonance imaging lesions. Ann Neurol 1993; 33: 480-89.
-
(1993)
Ann Neurol
, vol.33
, pp. 480-489
-
-
Smith, M.E.1
Stone, L.A.2
Albert, P.S.3
Frank, J.A.4
-
24
-
-
0007949236
-
Correlations of baseline MRI burden of disease and lesion activity with subsequent activity: Implications for future MS therapeutic trial
-
Zhao GJ, Li DKB, Wang ZY, Cheng Y, Paty DW and the UBC MSMRI Research Group. Correlations of baseline MRI burden of disease and lesion activity with subsequent activity: Implications for future MS therapeutic trial. Neurology 1999; 52 (Suppl 2): P04.109.
-
(1999)
Neurology
, vol.52
, Issue.SUPPL. 2
-
-
Zhao, G.J.1
Li, D.K.B.2
Wang, Z.Y.3
Cheng, Y.4
Paty, D.W.5
-
26
-
-
0037122957
-
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
-
Brex PA, Ciccarelli O, O'Riordan JI, Sailer M. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2001; 346: 158-64.
-
(2001)
N Engl J Med
, vol.346
, pp. 158-164
-
-
Brex, P.A.1
Ciccarelli, O.2
O'Riordan, J.I.3
Sailer, M.4
-
27
-
-
0035960564
-
Sample size estimations for MRI monitored trials of MS comparing new vs. standard treatments
-
Sormani MP, Rovaris M, Bagnato F, Molyneux P et al. Sample size estimations for MRI monitored trials of MS comparing new vs. standard treatments. Neurology 2001; 57: 1883-85.
-
(2001)
Neurology
, vol.57
, pp. 1883-1885
-
-
Sormani, M.P.1
Rovaris, M.2
Bagnato, F.3
Molyneux, P.4
|